Table 2.
Prevalence of very good/good self-rated health among all PLHIV, PLHIV on antiretroviral treatment and PLHIV on antiretroviral treatment virally suppressed
| All PLHIV | Very good/good self-rated health among all PLHIV | On ART | Very good/good self-rated health among PLHIV on ART | On ART virally suppressed | Very good/good self-rated health among PLHIV on ART virally suppressed | ||||
|---|---|---|---|---|---|---|---|---|---|
| n | n | % (95% CI) | n | n | % (95% CI) | n | n | % (95% CI) | |
| Gender | |||||||||
| Male | 591 | 404 | 68.4 (64.4–72.1) | 571 | 398 | 69.7 (65.8–73.4) | 516 | 377 | 73.1 (69.0–76.8) |
| Female | 195 | 127 | 65.1 (58.0–71.8) | 193 | 126 | 65.3 (58.1–72.0) | 177 | 120 | 67.8 (60.4–74.6) |
| Transgender | 12 | 8 | 66.7 (34.9–90.0) | 11 | 7 | 63.6 (30.8–89.1) | 8 | 6 | 75.0 (34.9–96.8) |
| Unknown | 2 | 1 | 50.0 (1.3–98.7) | 1 | 0 | 0 | 1 | 0 | 0 |
| Age group (years) | |||||||||
| < 35 | 111 | 86 | 77.5 (68.6–84.9) | 103 | 82 | 79.6 (70.5–86.9) | 91 | 73 | 80.2 (70.6–87.8) |
| 35–50 | 282 | 197 | 69.9 (64.1–75.2) | 274 | 194 | 70.8 (65.0–76.1) | 240 | 182 | 75.8 (69.9–81.1) |
| 51–60 | 299 | 188 | 62.9 (57.1–68.4) | 295 | 187 | 63.4 (57.6–68.9) | 274 | 182 | 66.4 (60.5–72.0) |
| > 60 | 95 | 60 | 63.2 (52.6–72.8) | 92 | 60 | 65.2 (54.6–74.9) | 87 | 59 | 67.8 (56.9–77.4) |
| Unknown | 13 | 9 | 69.2 (38.6–90.9) | 12 | 8 | 66.7 (34.9–90.1) | 10 | 7 | 70.0 (34.8–93.3) |
| Educational level | |||||||||
| Illiteracy/Primary education | 327 | 189 | 57.8 (52.2–63.2) | 319 | 188 | 58.9 (53.3–64.4) | 285 | 176 | 61.8 (55.8–67.4) |
| Secondary education | 258 | 183 | 70.9 (65.0–76.4) | 252 | 180 | 71.4 (65.4–76.9) | 229 | 172 | 75.1 (69.0–80.6) |
| University education | 180 | 150 | 83.3 (77.1–88.5) | 171 | 146 | 85.4 (79.2–90.3) | 159 | 139 | 87.4 (81.2–92.1) |
| Unknown | 35 | 18 | 51.4 (34.0–68.6) | 34 | 17 | 50.0 (32.4–67.6) | 29 | 16 | 55.2 (35.7–73.6) |
| Country of birth | |||||||||
| Spain | 631 | 412 | 65.3 (61.4–69.0) | 613 | 406 | 66.2 (62.3–70.0) | 566 | 390 | 68.9 (64.9–72.7) |
| Other | 164 | 123 | 75.0 (67.7–81.4) | 158 | 120 | 76.0 (68.5–82.4) | 132 | 109 | 82.6 (75.0–88.6) |
| Unknown | 5 | 5 | 100.0 (−) | 5 | 5 | 100 (48.0–100) | 4 | 4 | 100 (39.8–100) |
| Residence | |||||||||
| Living with family | 478 | 330 | 69.0 (63.4–71.9) | 467 | 326 | 69.8 (65.4–73.9) | 428 | 309 | 72.2 (67.7–76.4) |
| Living alone | 216 | 142 | 65.7 (59.0–72.0) | 208 | 139 | 66.8 (60.0–73.2) | 188 | 136 | 72.3 (65.4–78.6) |
| Closed institutions/Prison/ Homeless | 31 | 11 | 35.5 (19.2–54.6) | 31 | 11 | 35.5 (19.2–54.6) | 25 | 9 | 36.0 (18.0–57.5) |
| Other | 70 | 56 | 80.0 (68.7–88.6) | 65 | 54 | 83.1 (71.7–91.2) | 59 | 48 | 81.4 (69.1–90.3) |
| Unknown | 5 | 1 | 20.0 (0.5–71.6) | 5 | 1 | 20.0 (0.5–71.6) | 2 | 1 | 50.0 (1.2–98.7) |
| Employment status | |||||||||
| Employed | 430 | 353 | 82.1 (78.1–85.6) | 421 | 348 | 82.7 (78.7–86.2) | 389 | 333 | 85.6 (81.7–88.9) |
| Unemployed | 139 | 65 | 46.8 (38.3–55.4) | 126 | 61 | 48.4 (39.4–57.5) | 105 | 54 | 51.4 (41.5–61.3) |
| Retired/disabled | 184 | 86 | 46.7 (39.4–54.2) | 182 | 86 | 47.2 (39.8–54.8) | 167 | 82 | 49.1 (41.3–56.9) |
| Student | 23 | 20 | 87.0 (66.4–97.2) | 23 | 20 | 87.0 (66.4–97.2) | 22 | 19 | 86.4 (65.1–97.1) |
| Other/ unknown | 24 | 16 | 66.7 (44.7–84.4) | 24 | 16 | 66.7 (44.7–84.4) | 19 | 15 | 78.9 (54.4–93.9) |
| Mode of transmission | |||||||||
| Heterosexual | 246 | 171 | 69.5 (63.3–75.2) | 240 | 168 | 70.0 (63.8–75.7) | 216 | 161 | 74.5 (68.2–80.2) |
| MSM | 293 | 228 | 77.8 (72.6–82.4) | 282 | 223 | 79.1 (73.9–83.7) | 260 | 210 | 80.8 (75.4–85.4) |
| PWID | 195 | 101 | 51.8 (44.5–59.0) | 192 | 101 | 52.6 (45.3–59.8) | 169 | 95 | 56.2 (48.4–63.8) |
| Other/ unknown | 66 | 40 | 60.6 (47.8–72.4) | 62 | 39 | 62.9 (49.7–74.8) | 57 | 37 | 64.9 (51.1–77.1) |
| HIV infection stage | |||||||||
| Asymptomatic | 386 | 299 | 77.5 (73.0–81.5) | 378 | 296 | 78.3 (73.8–82.4) | 353 | 280 | 79.3 (74.7–83.4) |
| Symptomatic non AIDS | 126 | 80 | 63.5 (54.4–71.9) | 122 | 77 | 63.1 (53.9–71.7) | 111 | 72 | 64.9 (55.2–73.7) |
| AIDS | 267 | 144 | 53.9 (47.8–60.0) | 257 | 143 | 55.6 (49.3–61.8) | 224 | 141 | 63.0 (56.3–69.3) |
| Unknown | 21 | 17 | 80.9 (58.1–94.6) | 19 | 15 | 78.9 (54.4–93.9) | 14 | 10 | 71.4 (41.9–91.6) |
| Viral load < 200 copies/ml (last determination) | |||||||||
| Yes | 704 | 503 | 71.4 (68.0–74.8) | 702 | 503 | 71.6 (68.2–75.0) | – | – | – |
| No | 71 | 24 | 33.8 (23.0–46.0) | 56 | 17 | 30.4 (18.8–44.0) | – | – | – |
| Unknown | 25 | 13 | 52.0 (31.3–72.2) | 18 | 11 | 61.1 (35.7–82.7) | – | – | – |
| CD4 count (last determination) | |||||||||
| < 200 | 67 | 14 | 20.9 (11.9–32.6) | 61 | 12 | 19.7 (10.6–31.8) | 36 | 10 | 27.8 (14.2–45.2) |
| 200–349 | 92 | 48 | 52.2 (41.5–62.7) | 89 | 47 | 52.8 (51.9–63.5) | 76 | 91 | 59.2 (47.3–70.4) |
| 350–499 | 116 | 71 | 61.2 (51.7–70.1) | 112 | 68 | 60.7 (51.0–69.8) | 99 | 60 | 60.6 (50.2–70.3) |
| > =500 | 499 | 391 | 78.4 (74.5–81.9) | 496 | 391 | 78.8 (75.0–82.3) | 483 | 381 | 78.9 (75.0–82.4) |
| Unknown | 26 | 16 | 61.5 (40.6–79.8) | 18 | 13 | 72.2 (46.5–90.3) | 8 | 7 | 87.5 (47.3–99.7) |
| Comorbidities | |||||||||
| Yes | 88 | 29 | 33.0 (23.3–43.8) | 87 | 29 | 33.3 (23.6–44.3) | 72 | 27 | 37.5 (26.4–49.7) |
| No/ Unknown | 712 | 511 | 71.8 (66.3–75.0) | 689 | 502 | 72.9 (69.3–76.1) | 630 | 476 | 75.6 (72.0–78.9) |
| Antiretroviral treatment | |||||||||
| Yes | 776 | 531 | 68.4 (65.0–71.7) | – | – | – | – | – | – |
| No | 18 | 8 | 44.4 (21.5–69.2) | – | – | – | – | – | – |
| Unknown | 6 | 1 | 16.7 (0.4–64.1) | – | – | – | – | – | – |
| Adherence | |||||||||
| Optimal | 653 | 471 | 72.1 (68.5–75.5) | 653 | 471 | 72.1 (68.5–75.5) | 611 | 451 | 73.8 (70.1–77.3) |
| Suboptimal | 68 | 36 | 52.9 (40.4–65.1) | 68 | 36 | 52.9 (40.4–65.2) | 56 | 31 | 55.4 (41.5–68.7) |
| Very bad | 25 | 3 | 12.0 (2.5–31.2) | 25 | 3 | 12.0 (2.5–31.2) | 8 | 1 | 12.5 (3.2–52.7) |
| Unknown | 30 | 21 | 70.0 (50.6–85.2) | 30 | 21 | 70.0 (50.6–85.3) | 27 | 20 | 74.1 (53.7–88.9) |
| No/unknown ART | 24 | 9 | 37.5 (18.8–59.4) | – | – | – | – | – | – |
| Years since HIV diagnosis | |||||||||
| < 2 | 73 | 42 | 57.5 (45.4–69.0) | 59 | 34 | 57.6 (44.1–70.4) | 38 | 27 | 71.1 (54.1–84.6) |
| 2–5 | 111 | 86 | 77.5 (68.6–84.8) | 109 | 86 | 78.9 (70.0–86.1) | 99 | 81 | 81.8 (72.3–88.6) |
| 6–10 | 121 | 93 | 76.9 (68.3–84.0) | 120 | 93 | 77.5 (69.0–84.6) | 110 | 89 | 80.9 (72.3–87.8) |
| 11–15 | 111 | 77 | 69.4 (59.9–77.8) | 110 | 77 | 70.0 (60.5–78.4) | 104 | 75 | 72.1 (62.5–80.5) |
| > 15 | 374 | 233 | 62.3 (57.2–67.2) | 369 | 233 | 63.1 (58.0–68.1) | 345 | 225 | 65.2 (60.0–70.2) |
| Unknown | 10 | 9 | 90.0 (55.5–99.7) | 9 | 8 | 88.9 (51.7–99.7) | 6 | 6 | 100 (54.1–100) |
| Total | 800 | 540 | 67.5 (64.1–70.7) | 776 | 531 | 68.4 (65.0–71.7) | 702 | 503 | 71.7 (68.2–75.0) |
95% CI Confidence interval 95%, PLHIV People living with HIV, ART antiretroviral treatment, MSM Men who have sex with men, PWID People who injected drugs